Q-Line Biotech
Q-Line Biotech Limited is an Indian in-vitro diagnostics company incorporated in 2010 and headquartered in New Delhi. The company manufactures and markets biochemistry reagents, consumables, point-of-care devices, and pathology equipment serving diagnostic laboratories, hospitals, and medical colleges through a B2B distribution model. Listed on NSE Emerge in May 2026, the company operates across 15+ countries with 150+ national and international clients and employs over 200 staff.
The man who grew Reliance Mutual Fund's equity AUM from ₹200 Cr to nearly ₹80,000 Cr, one of the greatest fund management runs in Indian history. After leaving Reliance, Sunil Singhania launched Abakkus Asset Management (2018), which now manages ~₹36,700 Cr. Voted Best Fund Manager by Outlook Business (2016 & 2017). First Indian elected to the CFA Institute Board of Governors. His direct disclosed equity portfolio has consistently backed emerging industrials and financials before they became consensus.